Health authorities worldwide are on high alert as a more lethal strain of mpox (formerly known as monkeypox) continues to spread across multiple African countries. The Democratic Republic of Congo (DRC) has reported over 14,000 cases and 511 deaths, with the virus now detected in Burundi, Kenya, Rwanda, and Uganda—countries that had not previously encountered this strain.
A Worsening Situation in Central Africa
The World Health Organization (WHO) has voiced concerns about the severity of the outbreak in the DRC, where the more dangerous Clade Ib strain is primarily responsible. While this variant is deadlier, there is no evidence suggesting it is more transmissible than other strains. WHO Director-General Dr. Tedros Adhanom Ghebreyesus highlighted the urgency of the situation, noting that the number of cases reported in the first half of 2024 equals the total number for 2023.
Global Health
In response to the growing threat, WHO is considering whether to declare the outbreak a Public Health Emergency of International Concern. The U.S. Centers for Disease Control and Prevention (CDC) has also issued a health advisory, urging heightened vigilance, particularly among those who have recently traveled to affected regions.
Understanding Mpox
Mpox is a viral disease that spreads through close contact, including touching, kissing, sexual activity, and exposure to contaminated materials. Symptoms can range from fever and painful rashes to headaches and muscle pain. Historically confined to Central and West Africa, the virus gained international attention after spreading to Europe and North America in 2022.
Vaccine and Containment Efforts
To curb the outbreak, WHO has initiated an Emergency Use Listing process to expedite access to approved mpox vaccines, particularly for lower-income countries. Nigeria and the DRC have already approved vaccines for emergency use. The CDC continues to recommend vaccination for individuals at high risk or those exposed to the virus.
The Road Ahead
Dr. Michael Ryan, Executive Director of WHO’s Health Emergencies Program, emphasized the need for international cooperation and funding to stop the virus's spread. WHO has already allocated $1 million from its Contingency Fund for Emergencies but stresses that a more significant global effort is required.
As the situation evolves, staying informed and following public health advice is crucial in containing the spread of this deadly strain of mpox.
Comments